MedTrace Logo

Sleep Quality in (COPD) Patients (COPD: Chronic Obstructive Pulmonary Disease)

NCT03290014 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2017-09-21

No results posted yet for this study

Summary

Patients with COPD, in addition to daytime symptoms, may suffer from nocturnal disturbances. The frequency of nocturnal problems has been reported to be higher in COPD than in the general population and it currently affects up to 50% of patients.

The CASIS questionnaire includes 7 questions and it has been recently validated as an objective tool to evaluate nocturnal symptoms in patients with asthma and COPD. The present study aims to study the validity of the CASIS questionnaire as a predictor of sleep quality measured by objective polysomnographic parameters.

Conditions

Interventions

DIAGNOSTIC_TEST

polysomnography

Monitoring of brain activity and respiratory variables during sleep

DIAGNOSTIC_TEST

Actigraphy

monitoring daily physical activity for 7 days

DIAGNOSTIC_TEST

Osler test

Evaluation of subjects´ ability to remain awake

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • Hospital Universitari Vall d'Hebron Research Institute

    lead OTHER

Principal Investigators

  • Marc Miravitlles, PhD · Vall d´Hebron Institut de Recerca

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2018-06-30
Completion
2018-09-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03290014 on ClinicalTrials.gov